Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 4 × Hemorrhage × Enoxaparin × Clear all

Phase

Phase NA 1 Phase 4 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Venous Thromboembolism 1 Thrombosis 1 Thromboembolism 1 Thrombocytopenia 1 Sarcoma 1 Pancreatic Neoplasms 1 Hemorrhage 1 Hematoma 1 Gastrointestinal Neoplasms 1 Fibrosis 1 Carcinoma, Hepatocellular 1 Bone Neoplasms 1

Interventions

Tranexamic Acid 2 Misoprostol 2 carbetocin 1 Vitamin B 6 1 Vasopressins 1 Uterine Artery Embolization 1 Tourniquets 1 Terlipressin 1 Sodium Chloride 1 Sensitivity Training Groups 1 Rivaroxaban 1 Oxytocin 1 Ibuprofen 1 Ethamsylate 1 Enoxaparin 1 Dalteparin 1 Bupivacaine 1 Acetaminophen 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05245877 2025-02-14

PREPOSTEROUS2

Helsinki University Central Hospital

Phase 4 Recruiting

Gastrointestinal

Hemorrhage, Pancreatic Neoplasms, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡